ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NXGL NexGel Inc

2.25
0.00 (0.00%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
NexGel Inc NASDAQ:NXGL NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.25 0.0001 3.25 2.25 2.1501 2.21 1,660 05:00:08

NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

21/03/2024 1:00pm

GlobeNewswire Inc.


NexGel (NASDAQ:NXGL)
Historical Stock Chart


From Mar 2024 to Jun 2024

Click Here for more NexGel Charts.

NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced it will report its financial results for the fourth quarter and full year ended December 31, 2023, after the market closes on March 28, 2024. Following the release of its financial results, the Company will host a conference call at 4:30 P.M. ET on the same day.

Fourth Quarter and Full Year 2023 Financial Results Conference Call

Date: March 28, 2024Time: 4:30 P.M. ETLive Call: + 1-800-274-8461 (U.S. Toll Free) or + 1-203-518-9814 (International)Webcast: Events and Presentations

For interested individuals unable to join the conference call, a replay will be available through April 11, 2024 by dialing + 1-844-512-2921 (U.S. Toll Free) or + 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 1155204. An archived version of the webcast will also be available for 90 days.

About NEXGEL, INC.

NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.

Investor Contacts:Valter Pinto, Managing DirectorKCSA Strategic Communications212.896.1254valter@kcsa.com

1 Year NexGel Chart

1 Year NexGel Chart

1 Month NexGel Chart

1 Month NexGel Chart

Your Recent History